Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial efflux pumps and membrane ATPases are integral membrane proteins essential for bacterial survival, homeostasis, and defense. Efflux pumps are specialized transporters that actively extrude a wide range of substrates, including antibiotics, heavy metals, and toxins, thereby serving as a major mechanism of multidrug resistance (MDR) (Li et al., 2015). These pumps are categorized into several families, such as the Resistance-Nodulation-Division (RND) and ATP-Binding Cassette (ABC) superfamilies, often utilizing the proton motive force or ATP hydrolysis as an energy source (Du et al., 2018). Membrane ATPases, including F-type and P-type ATPases, are responsible for maintaining electrochemical gradients and synthesizing or hydrolyzing ATP to drive cellular work (Kühlbrandt, 2004). In clinical practice, targeting these proteins—such as with the F-type ATPase inhibitor Bedaquiline—provides a potent strategy against recalcitrant infections like tuberculosis (Andries et al., 2005). However, developing inhibitors for these targets is challenging due to the potential for off-target effects on human mitochondrial ATPases or homologous transporters, necessitating high selectivity to ensure patient safety (Piddock, 2006).
Inhibition of ATP synthase activity, competitive inhibition of efflux transporters, disruption of proton motive force, and potentiation of co-administered antibiotics.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial efflux pumps and membrane ATPases.